U.S. businesses complain about India trade practices

WASHINGTON Thu Jun 6, 2013 12:34am IST

Technical Sergeants from the U.S. Department of Defense display the flags of India and the United States before a bilateral meeting during the Shangri-La Dialogue Asia Security Summit in Singapore June 4, 2010. REUTERS/Carolyn Kaster/Pool/Files

Technical Sergeants from the U.S. Department of Defense display the flags of India and the United States before a bilateral meeting during the Shangri-La Dialogue Asia Security Summit in Singapore June 4, 2010.

Credit: Reuters/Carolyn Kaster/Pool/Files

Related Topics

WASHINGTON (Reuters) - Leading U.S. business groups on Wednesday urged President Barack Obama to act against what they said were "unacceptable" Indian trade practices that have hurt U.S. exports in areas ranging from pharmaceuticals to electronics.

The National Association of Manufacturers and other business groups expressed their concerns in a letter that was still being circulated on Wednesday to collect more signatures. It was expected to be sent to the White House within days.

"The government of India is discriminating against a wide range of U.S. exports, jeopardizing domestic jobs and putting at risk a growing bilateral trading relationship worth more than $60 billion last year," the groups said.

"These actions are unacceptable for a responsible middle-income country and rising global power," the groups said.

The letter is the latest sign of U.S. business frustration with Indian industrial policies that throw barriers to imports in bid to create domestic jobs.

"We urge the U.S. government immediately to initiate bilateral engagement at the highest levels and to coordinate closely with the European Union and other like-minded economies. If this engagement is not fruitful, we ask the U.S. government to respond purposefully, using all available trade tools and diplomatic engagement," the letter said.

The flurry of activity comes one day before White House international economic affairs adviser Michael Froman is scheduled to testify before the Senate Finance Committee on his nomination to be the next U.S. Trade Representative.

During that hearing, Froman could face question on an array of trade concerns, including Indian government policies.

The Washington-based Information Technology & Innovation Foundation in a recent paper accused the Indian government of "stripping" foreign biopharmaceutical companies of valuable patent protections and imposing local content requirements that could potentially block foreign equipment manufacturers from a huge section of the Indian market.

Linda Dempsey, vice president for international economic affairs at the National Association of Manufacturers, said business leaders want U.S. Secretary of State John Kerry to raise the concerns when he travels to India later this month for high-level talks.

"To have the type of strategic relationship that our government wants, we need to get these very important commercial and economic issues dealt with," Dempsey said.

"We all want to see manufacturing grow there in the United States. This is a threat to that ... To have other countries flout the economic system, to try to grow their economy at the expense of ours," she said.

(Reporting by Doug Palmer; Editing by Sandra Maler and Cynthia Osterman)

FILED UNDER:

"India's Daughter"

Reuters Showcase

Microfinance

Microfinance

Funding the unfunded: India helps small business borrow to grow  Full Article 

Insurance Sector

Insurance Sector

UK healthcare firm Bupa sees strong growth in India  Full Article 

Sensex Rises

Sensex Rises

Sensex edges up; consumer and healthcare stocks rise  Full Article 

Market Eye

Market Eye

FTSE adds nine Indian firms as large-caps in Asia-Pacific ex-Japan index   Full Article 

Indian Ocean Diplomacy

Indian Ocean Diplomacy

PM Modi to ramp up help for Indian Ocean nations to counter China influence  Full Article 

ECB Bond-Buying

ECB Bond-Buying

ECB raises growth forecasts, to start printing money next week  Full Article 

China Economy

China Economy

China signals "new normal" with lower annual growth target  Full Article 

Pharma Sector

Pharma Sector

Panel recommends waiving late-stage trials for some drugs  Full Article 

E-commerce

E-commerce

China backs e-commerce expansion in win for Alibaba, JD.com  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device  Full Coverage